C Kozma

Summary

Publications

  1. pmc Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results
    Wayne Macfadden
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    BMC Psychiatry 11:167. 2011
  2. pmc Resource utilization in patients with schizophrenia who initiated risperidone long-acting therapy: results from the Schizophrenia Outcomes Utilization Relapse and Clinical Evaluation (SOURCE)
    Concetta Crivera
    Janssen Scientific Affairs, LLC, Raritan, New Jersey, USA
    BMC Psychiatry 11:168. 2011
  3. pmc Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
    Tim Lambert
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    Ann Gen Psychiatry 10:10. 2011
  4. pmc Predicting hospital admission and discharge with symptom or function scores in patients with schizophrenia: pooled analysis of a clinical trial extension
    Chris M Kozma
    University of South Carolina, Columbia, SC, USA
    Ann Gen Psychiatry 9:24. 2010
  5. doi request reprint Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP)
    C M Kozma
    University of South Carolina, Columbia, SC, USA
    J Med Econ 13:719-27. 2010
  6. doi request reprint Change in employment status over 52 weeks in patients with schizophrenia: an observational study
    C Kozma
    University of South Carolina, Columbia, SC, USA
    Curr Med Res Opin 27:327-33. 2011

Collaborators

  • Carla M Canuso
  • Concetta Crivera
  • Wayne Macfadden
  • Cherilyn Desouza
  • Lian Mao
  • Riad D Dirani
  • Stephen C Rodriguez
  • Tim Lambert
  • Kasem S Akhras
  • Jose M Olivares
  • Joseph Peuskens
  • Riad Dirani
  • An Jacobs
  • Patrick Otten

Detail Information

Publications6

  1. pmc Assessment of effectiveness measures in patients with schizophrenia initiated on risperidone long-acting therapy: the SOURCE study results
    Wayne Macfadden
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    BMC Psychiatry 11:167. 2011
    ..To evaluate effectiveness outcomes in a real-world setting in patients with schizophrenia initiating risperidone long-acting therapy (RLAT)...
  2. pmc Resource utilization in patients with schizophrenia who initiated risperidone long-acting therapy: results from the Schizophrenia Outcomes Utilization Relapse and Clinical Evaluation (SOURCE)
    Concetta Crivera
    Janssen Scientific Affairs, LLC, Raritan, New Jersey, USA
    BMC Psychiatry 11:168. 2011
    ..This analysis examined health care resource utilization from a 24-month observational study of patients with schizophrenia initiated on risperidone long-acting therapy (RLAT)...
  3. pmc Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium
    Tim Lambert
    Ortho McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA
    Ann Gen Psychiatry 10:10. 2011
    ..abstract:..
  4. pmc Predicting hospital admission and discharge with symptom or function scores in patients with schizophrenia: pooled analysis of a clinical trial extension
    Chris M Kozma
    University of South Carolina, Columbia, SC, USA
    Ann Gen Psychiatry 9:24. 2010
    ..The purpose of this analysis was to evaluate relationships between hospital admission or discharge and scores for symptom or functioning in patients with schizophrenia...
  5. doi request reprint Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP)
    C M Kozma
    University of South Carolina, Columbia, SC, USA
    J Med Econ 13:719-27. 2010
    ..The objective of this paper was to estimate the potential economic benefit of a reduction in inpatient hospital LOS for a common type of admission, community acquired pneumonia (CAP)...
  6. doi request reprint Change in employment status over 52 weeks in patients with schizophrenia: an observational study
    C Kozma
    University of South Carolina, Columbia, SC, USA
    Curr Med Res Opin 27:327-33. 2011
    ..The aim of this post-hoc analysis was to describe change in employment status over time in patients with schizophrenia...